The BLA was resubmitted in 2025, after Atara and the FDA aligned on the criteria and addressed the initial CRL conditions.
The FDA accepted Besremi's application for essential thrombocythemia, supported by SURPASS-ET and EXCEED-ET trial results, with a review target date of August 30, 2026. Essential thrombocythemia is a ...
Households in one part of the UK are being urged to claim cost of living payments worth up to £200 in January to help with ...
NBC Los Angeles on MSN
LA is giving away 280 sidewalk vending carts. Here's how to apply
Eligible sidewalk vendors operating in the city and county of Los Angeles could receive a free, health-code-compliant food ...
WTVC NewsChannel 9 on MSN
Tennessee to open new Education Freedom Scholarships Tuesday: Here are the updated rules
We are less than 24-hours from new applicants being able to apply for Education Freedom Scholarships.(---JOSH---) And for ...
You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events ...
LOS ANGELES – Los Angeles County and city officials Monday launched a $2.8 million program to provide more than 280 ...
VnExpress International on MSNOpinion
When it costs less to disregard food safety, choice is no-brainer for businesses
On Saturday evening, after the CEO of Ha Long Canned Food Company had been arrested, I met my neighbor who was throwing ...
Explore how Singaporeans are learning to eat better, with initiatives for preschooler nutrition education and protein support ...
VYVGART was well-tolerated with a safety profile consistent with the established profile of VYVGART in patients with AChR-Ab seropositive gMG and other indications. No new safety concerns were ...
The supermarket’s paid subscription costs £7.99 per month, with a free one-month trial to start new members off. For £7.99 ...
The ruling examined whether a microencapsulated iron product should be treated as a chemical preparation or a food supplement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results